Rom E. Eliaz - Concepedia

Author

Rom E. Eliaz

Ben-Gurion University of the Negev

Also Known As

R E Eliaz, R.E. Eliaz, Rom E. Eliaz, Rom Eliaz

Publications

937

Citations

H-Index

Concepts

All Affiliations

Ben-Gurion University of the Negev University of California, San Francisco Teva Pharmaceuticals (Israel)Weizmann Institute of Science

About

Rom E. Eliaz is an author at Ben-Gurion University of the Negev specializing in medicine, biomedical engineering, and engineering.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	6	6	516
2	Engineering	4	4	259
3	Biomedical Engineering	4	4	259
4	Biomolecular Engineering	3	3	205
5	Cell Biology	2	2	364

Rom E. Eliaz

Publications

914

Citations

H-Index

Page 1

	Year	Citations
Liposome-encapsulated doxorubicin targeted to CD44: a strategy to kill CD44-overexpressing tumor cells. Rom E. Eliaz, Francis C. Szoka PubMed Proteinlipid InteractionExpress Cd44ImmunologyGlycobiologyLiposome-encapsulated Doxorubicin	2001	330
Characterization of a polymeric PLGA-injectable implant delivery system for the controlled release of proteins Rom E. Eliaz, Joseph Kost Journal of Biomedical Materials Research Tissue EngineeringBiopolymer GelBiocompatible MaterialEngineeringPolymer Science	2000	159
Determination and Modeling of Kinetics of Cancer Cell Killing by Doxorubicin and Doxorubicin Encapsulated in Targeted Liposomes Rom E. Eliaz, Shlomo Nir, Cornelia Marty, Cancer Research	2004	151
Dopamine D2 receptor gene variants and response to rasagiline in early Parkinson’s disease: a pharmacogenetic study Mario Masellis, S.Karen Collinson, Natalie Freeman, Brain Molecular PharmacologyNeurodegenerative DiseasesSingle Nucleotide PolymorphismsMedicineGenetics	2016	61
Robust and prolonged gene expression from injectable polymeric implants Rom E. Eliaz, Francis C. Szoka Gene Therapy Tissue EngineeringRegenerative MedicineImplantable DeviceEngineeringGene Delivery	2002	54
Delivery of Soluble Tumor Necrosis Factor Receptor from In-Situ Forming PLGA Implants: In-Vivo Rom E. Eliaz, David Wallach, Joseph Kost Pharmaceutical Research	2000	49
Placebo-controlled evaluation of a bioengineered, cocaine-metabolizing fusion protein, TV-1380 (AlbuBChE), in the treatment of cocaine dependence Yossi Gilgun‐Sherki, Rom E. Eliaz, David J. McCann, Drug and Alcohol Dependence	2016	39
Interactions of Hyaluronan-Targeted Liposomes with Cultured Cells: Modeling of Binding and Endocytosis Rom E. Eliaz, Shlomo Nir, Francis C. Szoka Methods in enzymology on CD-ROM/Methods in enzymology Cultured CellsEngineeringHyaluronan-targeted LiposomesCell TraffickingEndocytic Pathway	2004	34
LONG-TERM PROTECTION AGAINST THE EFFECTS OF TUMOUR NECROSIS FACTOR BY CONTROLLED DELIVERY OF THE SOLUBLE p55 TNF RECEPTOR Rom E. Eliaz, David Wallach, Joseph Kost Cytokine InflammationCytokineAnti-inflammatoryMedicineApoptosis	1996	25
Characterization of a polymeric PLGA-injectable implant delivery system for the controlled release of proteins Rom E. Eliaz, Joseph Kost Journal of Biomedical Materials Research EngineeringBiomaterials DesignDesired Release RatesBiomedical EngineeringRegenerative Biomaterials	2000	12

Page 1